In particular, PhV IWG is involved in the preparation of new and revised guidance and EU procedures relating to PhV inspections.
The group provides a link with other groups, such as:
These involve joint meetings with pharmacovigilance assessors and contributions to training of inspectors and assessors.
The PhV inspectors maintain a dialogue with the inspectors of good clinical practice and good manufacturing practice.
The Pharmacovigilance Inspectors Working Group draws on the expertise of Member States' inspectorates.
PhV IWG meets four times a year at the European Medicines Agency with the representatives of PhV inspectorates involved in inspections related to human and veterinary products, across the European Economic Area. Observers from candidate countries and Switzerland also participate in the meetings.
If you have questions about the content below, please send a question to EMA.